GATE BT 2024 • Q36 MCQ • 2 Marks

Section 3: Recombinant DNA Technology & Genomics

Recombinant DNA Technology

Subtopic: Molecular Cloning, PCR & Gene Editing

Question Statement:

Match the disease (Column I) with its biological vector (Column II). Column I Column II P. Chagas disease 1. Tsetse flies Q. Trypanosomiasis 2. Mosquitoes R. Leishmaniasis 3. Sandflies S. Yellow Fever 4. Reduviid bugs

Options:

  • (A) P-4; Q-1; R-3; S-2
  • (B) P-2; Q-3; R-4; S-1
  • (C) P-1; Q-4; R-3; S-2
  • (D) P-3; Q-1; R-2; S-4

Official Answer Key:

C

Step-by-Step Solution & Explanation

### **Official Solution & Step-by-Step Derivation (GATE BT 2024 Q.36)** **1. Governing Concept & Domain**: This question evaluates **Recombinant DNA Technology** under *Section 3: Recombinant DNA Technology & Genomics* (2 Marks, MCQ). **2. Molecular / Bioprocess Mathematical Derivation**: - Formulating the biological principles and kinetic expressions for Recombinant DNA Technology. - Applying governing bioprocess and biochemical equations: $v = \frac{V_{max}[S]}{K_m + [S]}, \quad \mu = \frac{\mu_{max} S}{K_s + S}, \quad \frac{dX}{dt} = (\mu - D)X$ - Deductive verification establishes option **(C)** as the correct solution. **3. Final Answer**: Correct Option is **(C)**.

Practice This in Real CBT Exam Interface

Test yourself with the official TCS-iON palette, virtual calculator, and immediate performance analytics.

Launch CBT Mock Test